Publication | Open Access

The PPAR alpha agonist gemfibrozil is an ineffective treatment for spinal cord injured mice

Molecular PharmacologySpinal Cord InjuryPain MedicinePharmacologySpinal TraumaPharmacological AgentNeuropharmacologyExperimental PharmacologyPharmacotherapyNeurologyPain ManagementIneffective TreatmentMedicineSpinal Disorder